Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 1
1989 1
1990 2
1992 4
1993 2
1994 2
1995 1
1996 1
1997 7
1998 2
1999 3
2000 11
2001 10
2002 9
2003 7
2004 6
2005 10
2006 11
2007 19
2008 16
2009 17
2010 13
2011 13
2012 9
2013 11
2014 11
2015 7
2016 7
2017 8
2018 9
2019 7
2020 6
Text availability
Article attribute
Article type
Publication date

Search Results

222 results
Results by year
Filters applied: . Clear all
Page 1
Young adult outcomes in the follow-up of the multimodal treatment study of attention-deficit/hyperactivity disorder: symptom persistence, source discrepancy, and height suppression.
Swanson JM, Arnold LE, Molina BSG, Sibley MH, Hechtman LT, Hinshaw SP, Abikoff HB, Stehli A, Owens EB, Mitchell JT, Nichols Q, Howard A, Greenhill LL, Hoza B, Newcorn JH, Jensen PS, Vitiello B, Wigal T, Epstein JN, Tamm L, Lakes KD, Waxmonsky J, Lerner M, Etcovitch J, Murray DW, Muenke M, Acosta MT, Arcos-Burgos M, Pelham WE, Kraemer HC; MTA Cooperative Group. Swanson JM, et al. Among authors: Newcorn JH. J Child Psychol Psychiatry. 2017 Jun;58(6):663-678. doi: 10.1111/jcpp.12684. Epub 2017 Mar 10. J Child Psychol Psychiatry. 2017. PMID: 28295312 Free PMC article. Clinical Trial.
C. Keith Conners (1933-2017).
Stein MA, Newcorn JH. Stein MA, et al. Among authors: Newcorn JH. Am Psychol. 2018 Apr;73(3):292. doi: 10.1037/amp0000243. Am Psychol. 2018. PMID: 29648850
Efficacy and Safety of HLD200, Delayed-Release and Extended-Release Methylphenidate, in Children with Attention-Deficit/Hyperactivity Disorder.
Pliszka SR, Wilens TE, Bostrom S, Arnold VK, Marraffino A, Cutler AJ, López FA, DeSousa NJ, Sallee FR, Incledon B, Newcorn JH. Pliszka SR, et al. Among authors: Newcorn JH. J Child Adolesc Psychopharmacol. 2017 Aug;27(6):474-482. doi: 10.1089/cap.2017.0084. Epub 2017 Jul 21. J Child Adolesc Psychopharmacol. 2017. PMID: 29172680 Free PMC article. Clinical Trial.
Systematic Review: Nonmedical Use of Prescription Stimulants: Risk Factors, Outcomes, and Risk Reduction Strategies.
Faraone SV, Rostain AL, Montano CB, Mason O, Antshel KM, Newcorn JH. Faraone SV, et al. Among authors: Newcorn JH. J Am Acad Child Adolesc Psychiatry. 2020 Jan;59(1):100-112. doi: 10.1016/j.jaac.2019.06.012. Epub 2019 Jul 19. J Am Acad Child Adolesc Psychiatry. 2020. PMID: 31326580 Free article. Review.
Lisdexamfetamine Targets Amygdala Mechanisms That Bias Cognitive Control in Attention-Deficit/Hyperactivity Disorder.
Schulz KP, Krone B, Adler LA, Bédard AV, Duhoux S, Pedraza J, Mahagabin S, Newcorn JH. Schulz KP, et al. Among authors: Newcorn JH. Biol Psychiatry Cogn Neurosci Neuroimaging. 2018 Aug;3(8):686-693. doi: 10.1016/j.bpsc.2018.03.004. Epub 2018 Mar 19. Biol Psychiatry Cogn Neurosci Neuroimaging. 2018. PMID: 29661516 Clinical Trial.
A Double-Blind, Placebo-Controlled, Phase II Study to Determine the Efficacy, Safety, Tolerability and Pharmacokinetics of a Controlled Release (CR) Formulation of Mazindol in Adults with DSM-5 Attention-Deficit/Hyperactivity Disorder (ADHD).
Wigal TL, Newcorn JH, Handal N, Wigal SB, Mulligan I, Schmith V, Konofal E. Wigal TL, et al. Among authors: Newcorn JH. CNS Drugs. 2018 Mar;32(3):289-301. doi: 10.1007/s40263-018-0503-y. CNS Drugs. 2018. PMID: 29557078 Free PMC article. Clinical Trial.
Practitioner Review: Emotional dysregulation in attention-deficit/hyperactivity disorder - implications for clinical recognition and intervention.
Faraone SV, Rostain AL, Blader J, Busch B, Childress AC, Connor DF, Newcorn JH. Faraone SV, et al. Among authors: Newcorn JH. J Child Psychol Psychiatry. 2019 Feb;60(2):133-150. doi: 10.1111/jcpp.12899. Epub 2018 Apr 6. J Child Psychol Psychiatry. 2019. PMID: 29624671 Review.
222 results
Jump to page
Feedback